The Lancet6 小时
Weight-loss medications: promoting health and not harm
In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
The Lancet6 小时
Global health partnerships for a post-2030 agenda
Partnership is essential for solving complex global challenges. In global health, however, partnership has become associated with a specific model: public–private partnerships (PPPs), in which the key ...
The Lancet1 天
Wildfires in southern California: concerns for lung health
As of Jan 21, 2025, firefighters in southern California, USA, were still struggling to extinguish two of the largest ...
The Lancet1 天
US exit from WHO: it is about much more than WHO
The announcement by US President Donald Trump that the USA will withdraw from WHO1 will leave both a large financial gap and a political power vacuum in global health. The disruption endangers human ...
The Lancet1 天
An imminent hazard: Dhaka's unbreathable air
The harsh reality for the millions of people living in Dhaka, the capital of Bangladesh, is that every breath they take puts their health at risk. The city is at the top of the world's most polluted ...
The Lancet4 天
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...
The Lancet4 天
Protein-binding therapy: a new approach to lower cholesterol
Homozygous familial hypercholesterolaemia affects approximately 30 000 individuals worldwide.1,2 Patients have untreated high ...
The Lancet4 天
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a ...
aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...
The Lancet4 天
Antibody testing to predict SARS-CoV-2 risk in immunocompromised people
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
The Lancet4 天
Uveitis in juvenile idiopathic arthritis: when to stop adalimumab?
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. When DMARD treatment is ...
The Lancet4 天
Durability of patient benefit from CT-guided chest pain management
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
The Lancet4 天
Taking the temperature of humankind
Copyright: © 2025 Published by Elsevier Ltd. In 2015 this journal published a report by the Lancet Commission on Health and Climate Change, making the case that the ...